452 related articles for article (PubMed ID: 21602502)
1. Transcatheter intraarterial therapies: rationale and overview.
Lewandowski RJ; Geschwind JF; Liapi E; Salem R
Radiology; 2011 Jun; 259(3):641-57. PubMed ID: 21602502
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.
Duran R; Chapiro J; Schernthaner RE; Geschwind JF
Br J Radiol; 2015 Aug; 88(1052):20140564. PubMed ID: 25978585
[TBL] [Abstract][Full Text] [Related]
3. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.
Kritzinger J; Klass D; Ho S; Lim H; Buczkowski A; Yoshida E; Liu D
Clin Radiol; 2013 Jan; 68(1):1-15. PubMed ID: 22917735
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature.
Bester L; Meteling B; Boshell D; Chua TC; Morris DL
J Med Imaging Radiat Oncol; 2014; 58(3):341-52. PubMed ID: 24589204
[TBL] [Abstract][Full Text] [Related]
5. Interventional radiology for hepatocellular carcinoma.
Loffroy R
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
[TBL] [Abstract][Full Text] [Related]
6. Transarterial approaches to primary and secondary hepatic malignancies.
Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R
Nat Rev Clin Oncol; 2015 Aug; 12(8):481-9. PubMed ID: 25985939
[TBL] [Abstract][Full Text] [Related]
7. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy.
Kouri BE
Tech Vasc Interv Radiol; 2018 Dec; 21(4):205-222. PubMed ID: 30545499
[TBL] [Abstract][Full Text] [Related]
8. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
Salem R; Lewandowski RJ; Kulik L; Wang E; Riaz A; Ryu RK; Sato KT; Gupta R; Nikolaidis P; Miller FH; Yaghmai V; Ibrahim SM; Senthilnathan S; Baker T; Gates VL; Atassi B; Newman S; Memon K; Chen R; Vogelzang RL; Nemcek AA; Resnick SA; Chrisman HB; Carr J; Omary RA; Abecassis M; Benson AB; Mulcahy MF
Gastroenterology; 2011 Feb; 140(2):497-507.e2. PubMed ID: 21044630
[TBL] [Abstract][Full Text] [Related]
9. Catheter-based transarterial therapies for hepatocellular cancer.
Laroia ST; Morales SA; Laroia AT
Cleve Clin J Med; 2015 Dec; 82(12):828-34. PubMed ID: 26651891
[TBL] [Abstract][Full Text] [Related]
10. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
Trials; 2012 Aug; 13():144. PubMed ID: 22913492
[TBL] [Abstract][Full Text] [Related]
11. Intraarterial therapies for primary liver cancer: state of the art.
Chapiro J; Tacher V; Geschwind JF
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1157-67. PubMed ID: 24099626
[TBL] [Abstract][Full Text] [Related]
12. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS
J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684
[TBL] [Abstract][Full Text] [Related]
13. Advances in endovascular therapy to treat primary hepatocellular carcinoma.
Guo Z; Yu H; Liu C; Si T; Yang X; Zhang W; Xu Y; Li Y
Drug Discov Ther; 2015 Oct; 9(5):342-51. PubMed ID: 26632543
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
Liapi E; Geschwind JF
Ann Surg Oncol; 2010 May; 17(5):1234-46. PubMed ID: 20405328
[TBL] [Abstract][Full Text] [Related]
15. New interventions for liver tumors.
Ramsey DE; Geschwind JF
Semin Roentgenol; 2002 Oct; 37(4):303-11. PubMed ID: 12455128
[No Abstract] [Full Text] [Related]
16. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
Kallini JR; Gabr A; Salem R; Lewandowski RJ
Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
[TBL] [Abstract][Full Text] [Related]
17. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Fidelman N; Kerlan RK
AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
19. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Hickey RM; Lewandowski RJ; Salem R
Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
[TBL] [Abstract][Full Text] [Related]
20. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
Memon K; Lewandowski RJ; Riaz A; Salem R
Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
